According to AstraZeneca's latest financial reports the company's current revenue (TTM) is $47.61 B. In 2022 the company made a revenue of $44.35 B an increase over the years 2021 revenue that were of $37.41 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $45.81 B | 3.29% |
2022 | $44.35 B | 18.53% |
2021 | $37.41 B | 40.58% |
2020 | $26.61 B | 9.16% |
2019 | $24.38 B | 10.38% |
2018 | $22.09 B | -1.67% |
2017 | $22.46 B | -2.33% |
2016 | $23.00 B | -6.9% |
2015 | $24.70 B | -6.81% |
2014 | $26.51 B | 3.12% |
2013 | $25.71 B | -8.09% |
2012 | $27.97 B | -16.72% |
2011 | $33.59 B | 0.97% |
2010 | $33.26 B | 1.42% |
2009 | $32.80 B | 3.81% |
2008 | $31.60 B | 6.91% |
2007 | $29.55 B | 11.65% |
2006 | $26.47 B | 10.54% |
2005 | $23.95 B | 11.78% |
2004 | $21.42 B | 13.67% |
2003 | $18.84 B | 6.82% |
2002 | $17.64 B | -25.02% |
2001 | $23.53 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 88.32% | ๐บ๐ธ USA |
Novartis NVS | $49.92 B | 4.86% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 22.86% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | -15.76% | ๐บ๐ธ USA |
Eli Lilly LLY | $35.93 B | -24.53% | ๐บ๐ธ USA |
Sanofi SNY | $50.51 B | 6.10% | ๐ซ๐ท France |
Biogen BIIB | $9.66 B | -79.70% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 26.26% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.53 B | -4.36% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $38.54 B | -19.05% | ๐ฌ๐ง UK |